Strategic Acquisitions, Inc. filings document the public-company status, common-stock registration matters, and capital structure of the Nevada corporation trading under STQN. The record includes Form 15 certification activity under Exchange Act Section 12(g), subsequent material-event reporting on reporting status, and current reports covering corporate address changes.
Its SEC disclosures also cover unregistered restricted common-stock issuances, ownership concentration, issued and outstanding common shares, and late-filing notices for annual reports. These filings provide formal records of governance actions, securities-registration status, and compliance timing for the company.
Strategic Acquisitions, Inc. reports a change in the location of its principal executive offices. Effective December 16, 2025, the address moved from 51 JFK Parkway, Suite 135, Short Hills, New Jersey 07078 to 2464 Darts Cove Way, (Mount Pleasant) Charleston, South Carolina 29466-0101.
The company lists its telephone number as (908) 266-0541 and confirms that its common stock trades under the symbol STQN.
Strategic Acquisitions, Inc. (STQN) filed its Q3 2025 report. The company reported no revenue, a small Q3 net income of $3,347 due mainly to a reversal of over‑accrued expenses, and a year‑to‑date net loss of $24,244. Cash was $1,936 and shareholders’ deficit was $(2,951) as of September 30, 2025.
The balance sheet strengthened modestly after a related‑party Loan Cancellation Agreement converted $103,321 of working capital loans into equity, lifting additional paid‑in capital to $457,056. The company had 6,675,000 shares outstanding as of October 31, 2025. There were no loans or digital asset collateral outstanding at quarter‑end; the 2024 loan and related note were settled in July 2024.
Management disclosed substantial doubt about the ability to continue as a going concern given limited cash and ongoing losses, and stated plans to seek financing. Internal controls were deemed not effective due to material weaknesses. Subsequent event: the Board authorized funding Q4 by selling common stock from treasury; no shares had been sold as of October 31, 2025.